Descripción

Microbial diversity changes observed in ulcerative colitis compared to healthy controls are summarized, emphasizing the dysbiosis patterns common in active disease.

Figure 2

Chart

Source Paper

The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis.

Nutrients (2021)

PMID: 34071065

DOI: 10.3390/nu13061780

Cite This Figure

![Figure 2: Microbial diversity changes observed in ulcerative colitis compared to healthy controls are summarized, emphasizing the dysbiosis patterns common in active disease.]()

> Source: Jean-Frédéric LeBlanc et al. "The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis.." *Nutrients*, 2021. PMID: [34071065](https://pubmed.ncbi.nlm.nih.gov/34071065/)

<figure>
  <img src="" alt="Microbial diversity changes observed in ulcerative colitis compared to healthy controls are summarized, emphasizing the dysbiosis patterns common in active disease." />
  <figcaption>Figure 2. Microbial diversity changes observed in ulcerative colitis compared to healthy controls are summarized, emphasizing the dysbiosis patterns common in active disease.<br>  Source: Jean-Frédéric LeBlanc et al. "The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis.." <em>Nutrients</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34071065/">34071065</a></figcaption>
</figure>

Evidencia relacionada

Omega-3 Fatty Acids (EPA/DHA) para Ulcerative Colitis (UC)

Calificación C · 8 estudios